Circulating proteoglycans and glycosaminoglycans during critical illness

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Circulating glycosaminoglycan species in septic shock

  2014cited by this paper
• A personal voyage through the proteoglycan field.

  2014cited by this paper
• The Circulating Glycosaminoglycan Signature of Respiratory Failure in Critically Ill Adults*

  2014cited by this paper
• Evaluation of resuscitation fluids on endothelial glycocalyx, venular blood flow, and coagulation function after hemorrhagic shock in rats

  2013cited by this paper
• Molecular mechanisms of syndecan-4 upregulation by TNF-α in the endothelium-like EAhy926 cells.

  2013cited by this paper
• Fresh Frozen Plasma Lessens Pulmonary Endothelial Inflammation and Hyperpermeability After Hemorrhagic Shock and Is Associated With Loss of Syndecan 1

  2013cited by this paper
• Impact of Enzymatic Degradation of the Endothelial Glycocalyx on Vascular Permeability in an Awake Hamster Model

  2012cited by this paper
• Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy.

  2012cited by this paper
• Molecular functions of syndecan-1 in disease.

  2012cited by this paper
• Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability

  2012cited by this paper
• Vascular adhesion protein‐1 and syndecan‐1 in septic shock

  2012cited by this paper
• The volume-expanding effects of autologous liquid stored plasma following hemorrhage

  2012cited by this paper
• Modulation of Syndecan-1 Shedding after Hemorrhagic Shock and Resuscitation

  2011cited by this paper
• Heparan sulfate proteoglycans.

  2011cited by this paper
• Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix.

  2011cited by this paper
• Effect of charge on microvascular permeability in early experimental sepsis in the rat.

  2011cited by this paper
• Microvascular fluid exchange and the revised Starling principle.

  2010cited by this paper
• A MODEL FOR EVALUATING THE EFFECTS OF BLUNT SKELETAL MUSCLE TRAUMA ON MICROVASCULAR PERMEABILITY AND PLASMA VOLUME IN THE RAT

  2010cited by this paper
• Effects on Brain Edema of Crystalloid and Albumin Fluid Resuscitation after Brain Trauma and Hemorrhage in the Rat

  2010cited by this paper
• Composition of the endothelial glycocalyx and its relation to its thickness and diffusion of small solutes.

  2010cited by this paper
• Proteoglycans in health and disease: the multiple roles of syndecan shedding

  2010cited by this paper
• The Glycocalyx of the Human Umbilical Vein Endothelial Cell: An Impressive Structure Ex Vivo but Not in Culture

  2009cited by this paper
• Serum heparan sulfate levels are elevated in endotoxemia

  2009cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. 1992.

  2009cited by this paper
• Cecal ligation and incision: an acute onset model of severe sepsis in rats.

  2009cited by this paper
• Structural analysis of bikunin glycosaminoglycan.

  2008cited by this paper
• Quantitative determination of the glycosaminoglycan Delta-disaccharide composition of serum, platelets and granulocytes by reversed-phase high-performance liquid chromatography.

  2008cited by this paper
• Basement membrane heparan sulfate in atherogenesis and intimal hyperplasia

  2008cited by this paper
• The Quantification of Glycosaminoglycans: A Comparison of HPLC, Carbazole, and Alcian Blue Methods.

  2008cited by this paper
• Syndecan-1 Is an in Vivo Suppressor of Gram-positive Toxic Shock*

  2008cited by this paper
• Delayed fluid resuscitation in hemorrhagic shock induces proinflammatory cytokine response.

  2007cited by this paper
• Analytical method for the determination of disaccharides derived from keratan, heparan, and dermatan sulfates in human serum and plasma by high-performance liquid chromatography/turbo ionspray ionization tandem mass spectrometry.

  2007cited by this paper
• Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia

  2007cited by this paper
• Glomerular endothelial glycocalyx constitutes a barrier to protein permeability.

  2007cited by this paper
• The structure and function of the endothelial glycocalyx layer.

  2007cited by this paper
• Glycosaminoglycans and their proteoglycans: host‐associated molecular patterns for initiation and modulation of inflammation

  2006cited by this paper
• From bloodjournal.hematologylibrary.org at PENN STATE UNIVERSITY on February 23, 2013. For personal use only.

  2006cited by this paper
• Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids.

  2006cited by this paper
• Interactions between heparan sulfate and proteins: the concept of specificity

  2006cited by this paper
• The role of heparan sulphate in inflammation

  2006cited by this paper
• Effects of molecular size and chemical structure on renal and hepatic removal of exogenously administered chondroitin sulfate in rats.

  2006cited by this paper
• Spatial and temporal dynamics of the endothelium

  2005cited by this paper
• Spatial and temporal dynamics of the endothelium

  2005cited by this paper
• Endothelial heparan sulfate deficiency impairs L-selectin- and chemokine-mediated neutrophil trafficking during inflammatory responses

  2005cited by this paper
• Novel Heparan Sulfate Structures Revealed by Monoclonal Antibodies*

  2005cited by this paper
• RANTES (CCL5) induces a CCR5-dependent accelerated shedding of syndecan-1 (CD138) and syndecan-4 from HeLa cells and forms complexes with the shed ectodomains of these proteoglycans as well as with those of CD44.

  2004cited by this paper
• Activation of Syndecan-1 Ectodomain Shedding by Staphylococcus aureus α-Toxin and β-Toxin*

  2004cited by this paper
• Activation of syndecan-1 ectodomain shedding by Staphylococcus aureus alpha-toxin and beta-toxin.

  2004cited by this paper
• Markers of endothelial damage in organ dysfunction and sepsis

  2002cited by this paper
• Shedding of Syndecan-1 and -4 Ectodomains Is Regulated by Multiple Signaling Pathways and Mediated by a Timp-3–Sensitive Metalloproteinase

  2000cited by this paper
• What Else Can ‘Heparin’ Do?

  1999cited by this paper
• Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on "sepsis-related problems" of the European Society of Intensive Care Medicine.

  1998cited by this paper
• Quantitation of proteoglycans as glycosaminoglycans in biological fluids using an alcian blue dot blot analysis.

  1998cited by this paper
• Regulated Shedding of Syndecan-1 and -4 Ectodomains by Thrombin and Growth Factor Receptor Activation*

  1997cited by this paper
• Liver endothelial cell function is depressed only during hypodynamic sepsis.

  1997cited by this paper
• Microvascular blood flow resistance: role of endothelial surface layer.

  1997cited by this paper
• Hyaluronan: its nature, distribution, functions and turnover

  1997cited by this paper
• Suppression of Syndecan-1 Expression in Endothelial Cells by Tumor Necrosis Factor-α*

  1996cited by this paper
• Heparan sulfate proteoglycans. Essential co-factors in receptor-mediated processes with relevance to the biology of the vascular wall.

  1995cited by this paper
• Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns.

  1994cited by this paper
• Resistance to blood flow in microvessels in vivo.

  1994cited by this paper
• Molecular cloning of the major cell surface heparan sulfate proteoglycan from rat liver.

  1992cited by this paper
• Cell surface heparan sulfate proteoglycans from human vascular endothelial cells. Core protein characterization and antithrombin III binding properties.

  1992cited by this paper
• Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.

  1992cited by this paper
• Molecular cloning and expression of two distinct cDNA-encoding heparan sulfate proteoglycan core proteins from a rat endothelial cell line.

  1992cited by this paper
• Molecular cloning and characterization of N-syndecan, a novel transmembrane heparan sulfate proteoglycan

  1992cited by this paper
• Alteration in glycosaminoglycan metabolism and surface charge on human umbilical vein endothelial cells induced by cytokines, endotoxin and neutrophils.

  1992cited by this paper
• Ultrasensitive assays for endogenous antimicrobial polypeptides.

  1991cited by this paper
• Proteoglycans: structures and interactions.

  1991cited by this paper
• Characterization of a heparan sulfate and a peculiar chondroitin 4-sulfate proteoglycan from platelets. Inhibition of the aggregation process by platelet chondroitin sulfate proteoglycan.

  1991cited by this paper
• 3 Pharmacokinetics of heparin and low molecular weight heparin

  1990cited by this paper
• Pharmacokinetics of heparin and low molecular weight heparin.

  1990cited by this paper
• The synthesis of proteoglycans by human T lymphocytes.

  1990cited by this paper
• Molecular cloning of syndecan, an integral membrane proteoglycan

  1989cited by this paper
• Potential of human polymorphonuclear leukocytes to synthesize and secrete sulfated proteoglycans.

  1986cited by this paper
• Isolation and characterization of glycosaminoglycans in human plasma.

  1985cited by this paper
• Sulfated glycosaminoglycans in cultured endothelial cells from capillaries and large vessels of human and bovine origin.

  1985cited by this paper
• Colloids versus crystalloids as volume substitutes: clinical relevance of the serum oncotic pressure.

  1981cited by this paper
• The catabolism of intravenously injected heparan N-[35S] sulphate in the rat.

  1977cited by this paper
• The degradation of intravenously injected chondroitin 4-sulphate in the rat.

  1973cited by this paper
• The glycosaminoglycans of human plasma.

  1969cited by this paper
• Isolation and characterization of glycosaminoglycans from human leukocytes and platelets.

  1967cited by this paper

• No citing papers are available for this paper.